Department of Cardiology and Cardiac Surgery, Cardiocentro Ticino, Lugano, Switzerland.
Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland.
J Vasc Access. 2023 May;24(3):475-482. doi: 10.1177/11297298211039653. Epub 2021 Aug 16.
To evaluate the effectiveness of needle-free connectors to maintain Central Venous Catheter-CVC patency.
Loss of patency is a common complication associated with CVC. For patients, this can be stressful and painful, and can result in a delay in infusion therapy. Pressure-activated anti-reflux needle-free connectors are one of the most modern devices; however, no studies have compared this connector with the open-system three-way stopcock in terms of the incidence of CVC occlusion.
This study is a prospective before and after intervention study. From March to August 2018, an observation phase was conducted with the three-way stopcock as the standard central venous catheter hub and closure system (phase 1). After implementation of needle-free connectors (phase 2), post-intervention observations were made from September 2019 to January 2020 (phase 3).
Of 199 CVCs analyzed, 41.2% (40/97) occluded in at least one lumen in the first phase, and 13.7% (14/102) occluded after introducing the technological device, absolute risk reduction 27.5% (95% confidence interval 15.6%-39.4%). The lumens supported by needle-free connectors showed a higher probability of maintaining patency compared with three-way stopcocks. No differences were observed in the rate of infection.
Pressure-activated anti-reflux needle-free connectors are effective and safe devices suitable for the management of vascular access in cardiac patient care. Staff training, even on apparently simple devices, is essential to avoid the risk of infection.
评估无针连接器维持中心静脉导管(CVC)通畅的效果。
CVC 通畅性丧失是常见并发症。对患者而言,这会带来压力和痛苦,并可能导致输注治疗延迟。压力激活型反流无针连接器是最现代的设备之一;然而,尚无研究比较该连接器与开放式三通阀在 CVC 闭塞发生率方面的差异。
这是一项前瞻性干预前后研究。2018 年 3 月至 8 月,采用三通阀作为标准中心静脉导管接头和封闭系统(第 1 阶段)进行观察阶段。在引入无针连接器(第 2 阶段)后,于 2019 年 9 月至 2020 年 1 月进行干预后观察(第 3 阶段)。
在分析的 199 根 CVC 中,第 1 阶段至少有 1 个管腔闭塞的占 41.2%(40/97),引入技术装置后闭塞的占 13.7%(14/102),绝对风险降低 27.5%(95%置信区间 15.6%-39.4%)。无针连接器支持的管腔保持通畅的可能性更高。未观察到感染率的差异。
压力激活型反流无针连接器是有效且安全的设备,适用于心脏患者护理中血管通路的管理。即使是对明显简单的设备进行人员培训也是必不可少的,以避免感染风险。